BIOLASE Announces Pricing of $7M Public Offering
LAKE FOREST, Calif., Feb. 13, 2024 — Dental laser developer and manufacturer BIOLASE, Inc. announced the price of its public offering of 16,000,000 units. Gross proceeds, before deducting placement agent fees and other offering expenses, are expected to be approximately $7 million. The offering is expected to close on Feb. 15, subject to customary closing conditions. It follows Biolase's close of its $4.5 million underwritten public offering (Series J convertible redeemable preferred stock and warrants) last summer.